Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models

Keyphrases

• Recombinant 100%
• Viral Integration 100%
• Adeno-associated Viral 100%
• Genotoxicity 100%
• Clinical Trials 66%
• Murine Studies 66%
• Adverse Events 33%
• Gene Therapy 33%
• Europe 33%
• Gene Delivery 33%
• Clinical Application 33%
• Aggregate Data 33%
• Serious Adverse Events 33%
• Potential Risk 33%
• Recombinant Adeno-associated Virus (rAAV) 33%
• Recombinant Viral Vectors 33%
• Adenoviral 33%
• Multiple Diseases 33%
• Animal Disease Models 33%
• AAV Gene Therapy 33%
• Renaissance 33%
• Insertional mutagenesis 33%
• Clinical Gene Therapy 33%
• Disease Reporting 33%
• Liver Enzymes 33%
• Viral Treatment 33%
• Viral Gene Delivery 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Adverse Event 100%
• Gene Delivery 100%
• Genotoxicity 100%
• Mutagenesis 50%
• Adeno Associated Virus Vector 50%
• Liver Enzyme 50%
• Comorbidity 50%
• Diseases 50%

Nursing and Health Professions

• Gene Therapy 100%
• Genotoxicity 100%
• Adverse Event 66%
• Liver Enzyme 33%
• Gene Targeting 33%
• Adeno Associated Virus Vector 33%
• Viral Gene Delivery System 33%
• Comorbidity 33%
• Diseases 33%